Finch Therapeutics Group Inc

NASDAQ:FNCH   3:59:52 PM EDT
15.28
+0.77 (+5.31%)
Earnings Announcements

Finch Therapeutics Reports Third Quarter 2021 Financial Results

Published: 11/10/2021 12:23 GMT
Finch Therapeutics Group Inc (FNCH) - Finch Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates.
Finch Therapeutics Group Inc - Qtrly Total Revenue $11.3 Million Versus $1.8 Million.
Finch Therapeutics Group Inc - Qtrly Net Loss per Share $0.21.
Revenue is expected to be $5 Million
Adjusted EPS is expected to be -$0.32

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.